Parainfluenza virus-3 infection and mortality after hematopoietic stem cell transplantation: multivariable analysis
| Covariate . | HR3-150 . | 95% CI . | P . |
|---|---|---|---|
| Among all patients | |||
| No PIV-3 infection | 1.0 | ||
| PIV-3 URI | 1.3 | 1.1-1.6 | .02 |
| PIV-3 LRI | 3.4 | 2.4-4.7 | < .001 |
| Among patients with PIV-3 LRI | |||
| Copathogen present? | |||
| No | 1.0 | ||
| Yes | 2.75 | 1.4-5.4 | .003 |
| Ventilator requirement? | |||
| No | 1.0 | ||
| Yes | 3.29 | 1.2-9.0 | .02 |
| Covariate . | HR3-150 . | 95% CI . | P . |
|---|---|---|---|
| Among all patients | |||
| No PIV-3 infection | 1.0 | ||
| PIV-3 URI | 1.3 | 1.1-1.6 | .02 |
| PIV-3 LRI | 3.4 | 2.4-4.7 | < .001 |
| Among patients with PIV-3 LRI | |||
| Copathogen present? | |||
| No | 1.0 | ||
| Yes | 2.75 | 1.4-5.4 | .003 |
| Ventilator requirement? | |||
| No | 1.0 | ||
| Yes | 3.29 | 1.2-9.0 | .02 |
HR, indicates hazard ratio; URI, upper respiratory infections; LRI, lower respiratory tract infections; for other abbreviations, see Tables 1 and 2.
Adjusted for age, underlying disease, disease risk, CMV serostatus, donor type.